Terms: = Skin cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359
546 results:
1. The immune response-related genomic alterations in patients with malignant melanoma.
Li L; Xiang T; Li X
Medicine (Baltimore); 2024 Apr; 103(17):e37966. PubMed ID: 38669390
[TBL] [Abstract] [Full Text] [Related]
2. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
Ichimura N; Urata Y; Kobayashi T; Hibi H
Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
[TBL] [Abstract] [Full Text] [Related]
3. Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.
Matthies L; Amir-Kabirian H; Gebrekidan MT; Braeuer AS; Speth US; Smeets R; Hagel C; Gosau M; Knipfer C; Friedrich RE
PLoS One; 2024; 19(4):e0302017. PubMed ID: 38603731
[TBL] [Abstract] [Full Text] [Related]
4. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics.
Sukniam K; Manaise HK; Popp K; Popp R; Gabriel E
Cells; 2024 Mar; 13(6):. PubMed ID: 38534309
[TBL] [Abstract] [Full Text] [Related]
5. Correlation between large rearrangements and patient phenotypes in nf1 deletion syndrome: an update and review.
Pacot L; Girish M; Knight S; Spurlock G; Varghese V; Ye M; Thomas N; Pasmant E; Upadhyaya M
BMC Med Genomics; 2024 Mar; 17(1):73. PubMed ID: 38448973
[TBL] [Abstract] [Full Text] [Related]
6. ARID2 mutations may relay a distinct subset of cutaneous melanoma patients with different outcomes.
Akinjiyan FA; Nassief G; Phillipps J; Adeyelu T; Elliott A; Abdulla F; Zhou AY; Souroullas G; Kim KB; Vanderwalde A; Park SJ; Ansstas G
Sci Rep; 2024 Feb; 14(1):3444. PubMed ID: 38341515
[TBL] [Abstract] [Full Text] [Related]
7. Relevance of detection of RAF fusion transcripts in pan-negative melanoma in routine practice.
Delzenne G; Boileau M; Jamme P; Farchi O; Mortier L
Melanoma Res; 2024 Apr; 34(2):182-185. PubMed ID: 38329225
[TBL] [Abstract] [Full Text] [Related]
8. Global research trends in cutaneous neurofibromas: A bibliometric analysis from 2003 to 2022.
Wang J; Fu J; Zhou Y; Gao D; Qing J; Yang G
Skin Res Technol; 2024 Feb; 30(2):e13595. PubMed ID: 38279591
[TBL] [Abstract] [Full Text] [Related]
9. A Fucose-Containing Sulfated Polysaccharide from Spatoglossum schröederi Potentially Targets Tumor Growth Rather Than Cytotoxicity: Distinguishing Action on Human Melanoma Cell Lines.
Reis MBE; Maximo AI; Magno JM; de Lima Bellan D; Buzzo JLA; Simas FF; Rocha HAO; da Silva Trindade E; Camargo de Oliveira C
Mar Biotechnol (NY); 2024 Feb; 26(1):181-198. PubMed ID: 38273163
[TBL] [Abstract] [Full Text] [Related]
10. Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy.
Meraz-Torres F; Niessner H; Plöger S; Riel S; Schörg B; Casadei N; Kneilling M; Schaller M; Flatz L; Macek B; Eigentler T; Rieß O; Garbe C; Amaral T; Sinnberg T
J Exp Clin Cancer Res; 2024 Jan; 43(1):30. PubMed ID: 38263136
[TBL] [Abstract] [Full Text] [Related]
11. Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report.
Sassi I; Bouida MA; Hasnaoui A; Zemni I; Ben Dhieb T
J Med Case Rep; 2024 Jan; 18(1):15. PubMed ID: 38216958
[TBL] [Abstract] [Full Text] [Related]
12. Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.
Mazuelas H; Magallón-Lorenz M; Uriarte-Arrazola I; Negro A; Rosas I; Blanco I; Castellanos E; Lázaro C; Gel B; Carrió M; Serra E
JCI Insight; 2024 Jan; 9(3):. PubMed ID: 38175707
[TBL] [Abstract] [Full Text] [Related]
13. Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods.
Richey P; Funk M; Sakamoto F; Plotkin S; Ly I; Jordan J; Muzikansky A; Roberts J; Farinelli W; Levin Y; Garibyan L; Blakeley JO; Anderson RR
J Am Acad Dermatol; 2024 Apr; 90(4):767-774. PubMed ID: 38086517
[TBL] [Abstract] [Full Text] [Related]
14. Econazole selectively induces cell death in nf1-homozygous mutant tumor cells.
Lakes YB; Moye SL; Mo J; Tegtmeyer M; Nehme R; Charlton M; Salinas G; McKay RM; Eggan K; Le LQ
Cell Rep Med; 2023 Dec; 4(12):101309. PubMed ID: 38086379
[TBL] [Abstract] [Full Text] [Related]
15. Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancers.
Ross FA; Hawley SA; Russell FM; Goodman N; Hardie DG
Biochem J; 2023 Dec; 480(23):1951-1968. PubMed ID: 37962491
[TBL] [Abstract] [Full Text] [Related]
16. Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.
Wolters PL; Ghriwati NA; Baker M; Martin S; Berg D; Erickson G; Franklin B; Merker VL; Oberlander B; Reeve S; Rohl C; Rosser T; Vranceanu AM
Clin Trials; 2024 Feb; 21(1):73-84. PubMed ID: 37962219
[TBL] [Abstract] [Full Text] [Related]
17. Multidisciplinary neurofibromatosis conference in the management of patients with neurofibromatosis type 1 and schwannomatosis in a single tertiary care institution.
Debs P; Belzberg A; Blakeley J; Fayad L; Langmead S; Little E; Romo C; Schatz K; Slobogean B; Ahlawat S
Skeletal Radiol; 2024 May; 53(5):909-916. PubMed ID: 37950060
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.
Kallionpää RA; Peltonen S; Le KM; Martikkala E; Jääskeläinen M; Fazeli E; Riihilä P; Haapaniemi P; Rokka A; Salmi M; Leivo I; Peltonen J
Lab Invest; 2024 Jan; 104(1):100285. PubMed ID: 37949359
[TBL] [Abstract] [Full Text] [Related]
19. Tracing cancer evolution and heterogeneity using Hi-C.
Erdmann-Pham DD; Batra SS; Turkalo TK; Durbin J; Blanchette M; Yeh I; Shain H; Bastian BC; Song YS; Rokhsar DS; Hockemeyer D
Nat Commun; 2023 Nov; 14(1):7111. PubMed ID: 37932252
[TBL] [Abstract] [Full Text] [Related]
20. A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L; Bergqvist C; Sarin KY; Plotkin SR; Moertel C; Petersen AK; Cannon A; Berman Y; Pichard DC; Röhl C; Lessing A; Brizion B; Peiffer B; Ravaud P; Tran VT; Armand ML; Moryousef S; Ferkal S; Jannic A; Ezzedine K; Wolkenstein P;
Br J Dermatol; 2024 Jan; 190(2):216-225. PubMed ID: 37877514
[TBL] [Abstract] [Full Text] [Related]
[Next]
